cyclohexanol has been researched along with Mental Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, H; Coronado-Álvarez, A; Imperatori, C; Machado, S; Macías-Triana, L; Murillo-Rodríguez, E; Romero-Cordero, K; Tatum-Kuri, A; Vera-Barrón, A; Yamamoto, T | 1 |
| Vitiello, B | 1 |
| Chang, CH; Chen, SJ; Tsai, HC | 1 |
| Bujoreanu, IS; DeMaso, DR; Ibeziako, P | 1 |
| Preskorn, SH | 1 |
| Bogacz, R; Jones, MW; Kucewicz, MT; Tricklebank, MD | 1 |
| Capua, AD; Castrogiovanni, A; Ciani, V; Lazzeri, L; Luisi, S; Pacchierotti, C; Pasquini, R; Petraglia, F | 1 |
| Kranzler, J; Nemeroff, CB; Owens, MJ; Plott, SJ; Rao, SG; Vaishnavi, SN | 1 |
| Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Hornig, M | 1 |
| Daniels, S | 1 |
| Durkin, JP | 1 |
4 review(s) available for cyclohexanol and Mental Disorders
| Article | Year |
|---|---|
The synthetic CB
Topics: Analgesics; Animals; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Cannabinoids; Controlled Substances; Cyclohexanols; Dronabinol; Humans; Mental Disorders; Pain; Phenanthridines; Receptor, Cannabinoid, CB1 | 2021 |
Psychiatric concerns in pediatric epilepsy.
Topics: Adolescent; Amines; Anxiety Disorders; Bipolar Disorder; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Cyclohexanols; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Mental Disorders; Norepinephrine; Pregabalin; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride; Young Adult | 2010 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Dopamine; Dopamine Antagonists; Epinephrine; Humans; Mental Disorders; Norepinephrine; Prevalence; Psychotropic Drugs; Serotonin; Venlafaxine Hydrochloride | 1998 |
1 trial(s) available for cyclohexanol and Mental Disorders
| Article | Year |
|---|---|
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Climacteric; Cyclohexanols; Drug Repositioning; Female; Humans; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
8 other study(ies) available for cyclohexanol and Mental Disorders
| Article | Year |
|---|---|
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.
Topics: Bipolar Disorder; China; Cyclohexanols; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
Topics: Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Humans; Mental Disorders; Metabolic Clearance Rate; Pharmacogenetics; Phenotype; Psychotropic Drugs; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.
Topics: Action Potentials; Analysis of Variance; Animals; Biological Clocks; Brain Waves; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Confidence Intervals; Cyclohexanols; Dronabinol; Electric Stimulation; Evoked Potentials; Hippocampus; Immunosuppressive Agents; Male; Maze Learning; Memory, Short-Term; Mental Disorders; Nerve Net; Neurons; Prefrontal Cortex; Rats; Rats, Long-Evans; Reaction Time; Receptors, Cannabinoid; Statistics, Nonparametric; Time Factors | 2011 |
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Citalopram; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Milnacipran; Nerve Tissue Proteins; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Drug treatment for resistant depression.
Topics: Bias; Cyclohexanols; Drug Resistance; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Gabapentin in complicated school refusal.
Topics: Acetates; Adolescent; Amines; Comorbidity; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Mental Disorders; Phobic Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |